Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Fresenius Kabi PortugalFresenius Kabi Portugal
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
Fresenius Kabi Portugal

Fresenius Kabi Portugal

Zona Industrial do Lagedo, Santiago de Besteiros, 3465-157, PT

Last Update: 19/01/2026

View Profile
753/1000Fair

Como empresa global de cuidados de saúde, a Fresenius Kabi está Comprometida com a Vida. Os nossos produtos, tecnologias e serviços destinam-se ao tratamento de doentes críticos e crónicos. Com mais de 43.000 colaboradores e presença em mais de 100 países, o nosso vasto...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:134
Subsidiaries:31
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.hikma.com
767/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Fresenius Kabi Portugal

Fresenius Kabi Portugal

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi Portugal in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - Fresenius Kabi Portugal (X = Date, Y = Severity)

Fresenius Kabi Portugal cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Fresenius Kabi Portugal

Fresenius Kabi Portugal

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between Fresenius Kabi Portugal company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between Fresenius Kabi Portugal and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Fresenius Kabi Portugal and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Fresenius Kabi Portugal or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - Fresenius Kabi Portugal or Hikma Pharmaceuticals ?
Between Fresenius Kabi Portugal and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Fresenius Kabi Portugal and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-26422
SUMMARY

clash-verge-service-ipc before 2.3.0 has a world-reachable IPC endpoint, leading to local privilege escalation.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 8.4)
CVSS3
Base Score: 8.4
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.5
CVE-2026-11441
SUMMARY

A vulnerability was identified in theonedev onedev up to 15.0.5. This vulnerability affects the function canAccessIssue of the file /issues/ of the component Pull Request Handler. Such manipulation of the argument issue leads to improper authorization. It is possible to launch the attack remotely. Upgrading to version 15.0.6 is able to resolve this issue. It is advisable to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11440
SUMMARY

A vulnerability was determined in theonedev onedev up to 15.0.5. This affects an unknown part of the file /repositories/{projectId}/default-branch of the component REST API. This manipulation of the argument project.defaultBranch causes improper authorization. It is possible to initiate the attack remotely. Upgrading to version 15.0.6 is able to mitigate this issue. Upgrading the affected component is advised.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11439
SUMMARY

A vulnerability was found in theonedev onedev up to 15.0.5. Affected by this issue is some unknown functionality of the file /projects/ of the component Parent Project Handler. The manipulation of the argument project.parentId results in improper authorization. The attack may be performed from remote. Upgrading to version 15.0.6 can resolve this issue. It is recommended to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11438
SUMMARY

A vulnerability has been found in theonedev onedev up to 15.0.5. Affected by this vulnerability is an unknown functionality of the file /projects. The manipulation of the argument project.forkedFromId leads to improper authorization. The attack is possible to be carried out remotely. Upgrading to version 15.0.6 addresses this issue. Upgrading the affected component is recommended.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8